ARTICLE | Company News
Curalogic inflammation news
January 28, 2008 8:00 AM UTC
Curalogic restructured and reduced headcount by 50% to 7 and discontinued development of all its programs. The company made the decision after reviewing data from the failed Phase III RPE 04 trial of ...